Q2 2023 Holdings
Filed 2023-08-08 | 61 holdings | $328.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amgen Inc COM(AMGN) | COM | 031162100 | $26.0M | 117,246 | 7.9% |
| Incyte Corp(INCY) | COM | 45337C102 | $22.3M | 358,454 | 6.8% |
| Harmony Biosciences Hldgs(HRMY) | COM | 413197104 | $20.1M | 570,500 | 6.1% |
| Regeneron Pharms.(REGN) | COM | 75886F107 | $19.4M | 27,000 | 5.9% |
| Supernus Pharms.(SUPN) | COM | 868459108 | $15.7M | 523,500 | 4.8% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $15.6M | 975,227 | 4.8% |
| Alnylam Pharms.(ALNY) | COM | 02043Q107 | $15.5M | 81,600 | 4.7% |
| Apellis Pharms.(APLS) | COM | 03753U106 | $11.8M | 129,700 | 3.6% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $11.6M | 52,759 | 3.5% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $11.2M | 176,856 | 3.4% |
| Gilead Sciences(GILD) | COM | 375558103 | $11.1M | 144,584 | 3.4% |
| Illumina Inc(ILMN) | COM | 452327109 | $9.5M | 50,500 | 2.9% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $9.4M | 260,000 | 2.9% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $7.4M | 21,000 | 2.2% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $7.3M | 288,726 | 2.2% |
| Horizon Therapeutics | SHS | G4617B105 | $6.9M | 67,000 | 2.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $6.8M | 441,019 | 2.1% |
| Neurocrine Biosciences(NBIX) | COM | 64125C109 | $6.5M | 68,877 | 2.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $5.6M | 25,700 | 1.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $5.6M | 573,530 | 1.7% |
| Denali Therapeutics(DNLI) | COM | 24823R105 | $5.5M | 188,000 | 1.7% |
| Krystal Biotech(KRYS) | COM | 501147102 | $5.4M | 45,945 | 1.6% |
| Biomarin Pharm.(BMRN) | COM | 09061G101 | $5.1M | 58,656 | 1.5% |
| Madrigal Pharms.(MDGL) | COM | 558868105 | $4.2M | 18,300 | 1.3% |
| Axsome Therapeutics(AXSM) | COM | 05464T104 | $4.2M | 58,300 | 1.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $3.9M | 1,426,000 | 1.2% |
| Ultragenyx Pharm.(RARE) | COM | 90400D108 | $3.7M | 80,052 | 1.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $3.7M | 78,489 | 1.1% |
| Acadia Pharmaceuticals in(ACAD) | COM | 004225108 | $3.6M | 151,000 | 1.1% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $3.4M | 95,500 | 1.0% |
| Dyne Therapeutics(DYN) | COM | 26818M108 | $3.4M | 300,751 | 1.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.1M | 11,000 | 1.0% |
| Rocket Pharms.(RCKT) | COM | 77313F106 | $3.1M | 156,000 | 0.9% |
| Legend Biotech(LEGN) | SPONSORED ADS | 52490G102 | $2.6M | 38,000 | 0.8% |
| Zai Lab Ltd ADR (V1 Ord)(ZLAB) | ADR | 98887Q104 | $2.2M | 78,958 | 0.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.2M | 18,800 | 0.7% |
| Jazz Pharms.(JAZZ) | SHS USD | G50871105 | $2.1M | 17,200 | 0.6% |
| Ionis Pharms.(IONS) | COM | 462222100 | $1.8M | 43,000 | 0.5% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $1.7M | 67,500 | 0.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.6M | 48,099 | 0.5% |
| Beigene ADR(ONC) | Sponsored ADR | 07725L102 | $1.5M | 8,700 | 0.5% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $1.3M | 32,000 | 0.4% |
| Guardant Health(GH) | COM | 40131M109 | $1.3M | 36,500 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.2M | 37,000 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $981.8K | 25,500 | 0.3% |
| Intellia Therapeutics(NTLA) | COM | 45826J105 | $977.8K | 24,000 | 0.3% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $977.4K | 90,000 | 0.3% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $939.4K | 20,000 | 0.3% |
| I-Mab(NBP) | SPONSORED ADS | 44975P103 | $925.3K | 310,499 | 0.3% |
| Insmed Inc(INSM) | COM | 457669307 | $845.3K | 40,100 | 0.3% |